NCT06657157View on ClinicalTrials.gov

Peripheral Neuropathy in Patients Receiving Enfortumab Vedotin and Pembrolizumab As First Line Treatment for Metastatic or Locally Advanced Urothelial Carcinoma

RecruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

October 31, 2024

Primary Completion Date

July 31, 2026

Study Completion Date

October 31, 2026

Conditions
Urothelial Cancer
Trial Locations (2)

81377

RECRUITING

Department of Urology, LMU University Hospital, Ludwig-Maximilians-University Munich, Munich

81675

NOT_YET_RECRUITING

Department of Urology, Klinikum rechts der Isar, Technical University Munich, Munich

All Listed Sponsors
collaborator

Klinikum rechts der Isar, Technical University of Munich

UNKNOWN

lead

LMU Klinikum

OTHER